Related Experiment Videos
[Relationship between alterations of circulating cell-derived microparticles and glucocorticosteroid application]
Zeng-xin Gao1, Xi-sheng Weng, Gui-xing Qiu
1Department of Orthopedic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China.
Zhonghua Yi Xue Za Zhi
|August 30, 2008
Summary
High-dose glucocorticosteroid use significantly decreases circulating cell-derived microparticles (MPs). This reduction in MPs may contribute to microcirculation disturbances observed in patients.
Area of Science:
- Biomedical Science
- Hematology
- Cell Biology
Background:
- Cell-derived microparticles (MPs) are small vesicles released from cell membranes.
- MPs play roles in intercellular communication and hemostasis.
- Glucocorticosteroids are potent anti-inflammatory drugs with potential systemic effects.
Purpose of the Study:
- To investigate the impact of high-dose glucocorticosteroid therapy on circulating cell-derived microparticles (MPs).
- To determine if alterations in MP levels correlate with glucocorticosteroid application.
Main Methods:
- Peripheral blood samples were analyzed from patients receiving high-dose glucocorticosteroids and healthy controls.
- Plasma microparticles were quantified using three-color flow cytometry.
- Specific MP markers (CD31, CD42b, CD45, CD51/61, CD62E) were assessed.
Main Results:
- Patients on high-dose glucocorticosteroids exhibited significantly lower levels of total MPs and specific subsets (CD31+, CD45+, CD51/61+, CD31+CD42b+, CD31+CD45+).
- Statistical analysis confirmed significant differences between the glucocorticosteroid and control groups (P < 0.05 for all significant markers).
Conclusions:
- High-dose glucocorticosteroid administration leads to a notable decrease in plasma MPs.
- The reduction in circulating MPs may be a contributing factor to microcirculation disturbances.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...